Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

First application of Medtronic's neurostimulator in two patients with Parkinson's disease

Aug. 21, 1998

Yoshitomi claims safe and effective new antipsychotic agents

Aug. 21, 1998

Vertex solves 3D structure of JNK3, an enzyme implicated in epilepsy and stroke

Aug. 21, 1998

Available from NIH: compounds for the treatment of CNS disorders

Aug. 20, 1998

Zeldox development strategy disclosed

Aug. 20, 1998

Key U.S. patent issued for Emitasol

Aug. 20, 1998

GVS-111, a novel cognition-enhancing agent with a multifaceted mechanism of action

Aug. 20, 1998

French team synthesizes novel compounds with antihypoxic/antiischemic activity

Aug. 20, 1998

GR-196429 is a potent and selective agonist at melatonin receptors

Aug. 20, 1998

Akzo Nobel claims antipsychotic piperidine derivatives

Aug. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...